TELA Bio, Inc., a surgical reconstruction company, was created out of the desire to do things differently. Combining the drive and innovation of a start-up with a seasoned medical technology team, the company aims to commercialize a portfolio of products that are purposefully designed to address a range of unmet needs in soft tissue repair. Based in Malvern, Pennsylvania, this science-driven company is collaborating with leading surgeons to reinvigorate the soft tissue reconstruction market and bring cost-effective solutions to hospitals, surgeons and patients.
Please see our social media community guidelines at http://bit.ly/1UVcx0L
Please see our social media community guidelines at http://bit.ly/1UVcx0L
Location: United States, Pennsylvania, Malvern
Employees: 51-200
Phone: +1 484-320-2930
Total raised: $71.3M
Founded date: 2012
Investors 7
| Date | Name | Website |
| - | Checkmate ... | checkmatec... |
| - | EW Healthc... | ewhealthca... |
| - | Hercules C... | htgc.com |
| - | Quaker Par... | quakerpart... |
| - | OrbiMed | orbimed.co... |
| - | Signet Hea... | signetheal... |
| - | HighCape C... | highcape.c... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 26.03.2018 | - | $1M | - |
| 30.10.2017 | - | $25M | - |
| - | - | $45.3M | - |
Mentions in press and media 12
| Date | Title | Description |
| 28.08.2025 | FIRST CLINICAL EVIDENCE PUBLISHED ON AROA's ENIVO™ SYSTEM FOR SURGICAL DEAD SPACE MANAGEMENT. | AUCKLAND, New Zealand, Aug. 27, 2025 /PRNewswire/ -- AROA is pleased to announce the findings of the first in human study involving its new ENIVO platform technology. The study is the subject of a peer-reviewed publication entitled Prospect... |
| 31.05.2022 | TELA Bio Secures Up to $50 Million in Debt Financing from MidCap Financial | MALVERN, Pa., May 31, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outco... |
| 03.09.2021 | Recent Developments in Soft Tissue Reconstruction to be Explored on an Upcoming Episode of Advancements | JUPITER, Fla. (PRWEB) September 03, 2021 Scheduled to broadcast 4Q/2021, Advancements with Ted Danson will focus on breakthroughs in soft tissue repair solutions. Check local listings for more information. Hearing from experts in the field,... |
| 11.12.2018 | Tela Bio raises more than $2 million | Regenerative surgical implants company Tela Bio has brought in more than $2 million in investments, according to a recent U.S. Securities and Exchange Commission filing. The Malvern, Pa.–based company had sought to raise a total $3 million,... |
| 16.04.2018 | TELA Bio Announces Series B Investment by Checkmate Capital | TELA Bio®, Inc., a surgical reconstruction company leading the development and commercialization of OviTex® Reinforced BioScaffolds (RBSs) for soft tissue repair, today announced that Checkmate Capital, a strategic investment group based in... |
| 26.03.2018 | TELA Bio Lands $1M | MALVERN, PA, Surgical reconstruction company has raised $1 million from ProMedica Innovations Venture Fund. >> Click here for more funding data on TELA Bio >> To export TELA Bio funding data to PDF and Excel, click here T... |
| 26.03.2018 | TELA Bio Announces Investment Agreement with ProMedica Innovations Venture Fund | TELA Bio®, Inc., a surgical reconstruction company leading the development and commercialization of OviTex® Reinforced BioScaffolds (RBSs) for soft tissue repair, today announced that ProMedica, a mission-based, not-for-profit healthcare or... |
| 26.03.2018 | Tela Bio Receives $1M in Funding | Tela Bio, Inc., a Malvern, Pa.-based surgical reconstruction company focused on development and commercialization of OviTex® Reinforced BioScaffolds (RBSs) for soft tissue repair, received $1m in funding. ProMedica, a mission-based, not-for... |
| 30.10.2017 | Tela Bio Raises up to $25M in Equity Funding | Tela Bio, a Malvern, PA-based surgical reconstruction company that markets its proprietary OviTex™ portfolio of products for ventral hernia repair and abdominal wall reconstruction, is to raise up to $25m in equity funding. Pacira Pharmaceu... |
| 09.10.2014 | Stealth surgical reconstruction startup TELABio raises $45.3 million | Another board member is Kevin Rakin, who was CEO of Advanced BioHealing before it was acquired by the now-defunct Shire Regenerative Medicine. The company (which was the subject of a super messy Justice Department investigation, though that... |
Show more